Proteomic identification of immunoproteasome accumulation in formalin-fixed rodent spinal cords with experimental autoimmune encephalomyelitis

Journal of Proteome Research

Volumn 11, Issue 3, 2012, Pages 1791-1803

  Jain, Mohit Raja ^a   Li, Qing ^a   Liu, Tong ^a   Rinaggio, Joseph ^b   Ketkar, Amit ^a   Tournier, Vincent ^c   Madura, Kiran ^c   Elkabes, Stella ^d   Li, Hong ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d RWJ Barnabas Health   (United States)

Author keywords

biomarker; experimental autoimmune encephalomyelitis; formalin fixed paraffin embedded tissue; immunoproteasome; iTRAQ; mass spectrometry

Indexed keywords

FORMALDEHYDE; IMMUNOPROTEASOME; PARAFFIN; PROTEASOME; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE ANALYSIS; RAT; SCORING SYSTEM; SPINAL CORD; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING;

ANIMALS; ANTIGEN PRESENTATION; CYSTEINE ENDOPEPTIDASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOME; PROTEOMICS; RATS; RATS, INBRED LEW; SPINAL CORD; UP-REGULATION;

RATTUS; RODENTIA;

EID: 84863231370     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201043u     Document Type: Conference Paper

References (75)

1. Colucci-DAmato, L.; Farina, A.; Vissers, J. P.; Chambery, A. Quantitative neuroproteomics: classical and novel tools for studying neural differentiation and function Stem Cell Rev. 2011, 7 (1) 77-93
2. Bayes, A.; Grant, S. G. Neuroproteomics: understanding the molecular organization and complexity of the brain Nat. Rev. Neurosci. 2009, 10 (9) 635-46
3. Comabella, M.; Fernandez, M.; Martin, R.; Rivera-Vallve, S.; Borras, E.; Chiva, C.; Julia, E.; Rovira, A.; Canto, E.; Alvarez-Cermeno, J. C.; Villar, L. M.; Tintore, M.; Montalban, X. Cerebrospinal fluid Chitinase 3-like 1 levels are associated with conversion to multiple sclerosis Brain 2010, 133 (Pt 4) 1082-93
4. Di Domenico, F.; Owen, J. B.; Sultana, R.; Sowell, R. A.; Perluigi, M.; Cini, C.; Cai, J.; Pierce, W. M.; Butterfield, D. A. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimers disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression J. Neurosci. Res. 2010, 88 (16) 3566-77
5. Simon, S. L.; Lamoureux, L.; Plews, M.; Stobart, M.; LeMaistre, J.; Ziegler, U.; Graham, C.; Czub, S.; Groschup, M.; Knox, J. D. The identification of disease-induced biomarkers in the urine of BSE infected cattle Proteome Sci. 2008, 6, 23
6. Hsu, P. P.; Kang, S. A.; Rameseder, J.; Zhang, Y.; Ottina, K. A.; Lim, D.; Peterson, T. R.; Choi, Y.; Gray, N. S.; Yaffe, M. B.; Marto, J. A.; Sabatini, D. M. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling Science 2011, 332 (6035) 1317-22
7. Egger, M.; Jurets, A.; Wallner, M.; Briza, P.; Ruzek, S.; Hainzl, S.; Pichler, U.; Kitzmuller, C.; Bohle, B.; Huber, C. G.; Ferreira, F. Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome PLoS One 2011, 6 (2) e17278
8. Li, G.; Lee, L. S.; Li, M.; Tsao, S. W.; Chiu, J. F. Molecular changes during arsenic-induced cell transformation J. Cell Physiol. 2011, 226 (12) 3225-3232
9. Weist, S.; Brunkau, C.; Wittke, J.; Eravci, M.; Broedel, O.; Krause, E.; Stephanowitz, H.; Eravci, S.; Baumgartner, A. Effects of thawing, refreezing and storage conditions of tissue samples and protein extracts on 2-DE spot intensity Proteomics 2010, 10 (7) 1515-21
10. Skold, K.; Svensson, M.; Norrman, M.; Sjogren, B.; Svenningsson, P.; Andren, P. E. The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators Proteomics 2007, 7 (24) 4445-56
11. Fountoulakis, M.; Hardmeier, R.; Hoger, H.; Lubec, G. Postmortem changes in the level of brain proteins Exp. Neurol. 2001, 167 (1) 86-94
12. Fergenbaum, J. H.; Garcia-Closas, M.; Hewitt, S. M.; Lissowska, J.; Sakoda, L. C.; Sherman, M. E. Loss of antigenicity in stored sections of breast cancer tissue microarrays Cancer Epidemiol. Biomarkers Prev. 2004, 13 (4) 667-72
13. Xie, R.; Chung, J. Y.; Ylaya, K.; Williams, R. L.; Guerrero, N.; Nakatsuka, N.; Badie, C.; Hewitt, S. M. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections J. Histochem. Cytochem. 2011, 59 (4) 356-65
14. Ahram, M.; Flaig, M. J.; Gillespie, J. W.; Duray, P. H.; Linehan, W. M.; Ornstein, D. K.; Niu, S.; Zhao, Y.; Petricoin, E. F., 3rd; Emmert-Buck, M. R. Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications Proteomics 2003, 3 (4) 413-21
15. Zybailov, B.; Coleman, M. K.; Florens, L.; Washburn, M. P. Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling Anal. Chem. 2005, 77 (19) 6218-24
16. Ross, P. L.; Huang, Y. N.; Marchese, J. N.; Williamson, B.; Parker, K.; Hattan, S.; Khainovski, N.; Pillai, S.; Dey, S.; Daniels, S.; Purkayastha, S.; Juhasz, P.; Martin, S.; Bartlet-Jones, M.; He, F.; Jacobson, A.; Pappin, D. J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents Mol. Cell. Proteomics 2004, 3 (12) 1154-69
17. Liu, T.; Donahue, K. C.; Hu, J.; Kurnellas, M. P.; Grant, J. E.; Li, H.; Elkabes, S. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord J. Proteome Res. 2007, 6 (7) 2565-75
18. Grant, J. E.; Hu, J.; Liu, T.; Jain, M. R.; Elkabes, S.; Li, H. Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis J. Proteome Res. 2007, 6 (7) 2786-91
19. Jain, M. R.; Bian, S.; Liu, T.; Hu, J.; Elkabes, S.; Li, H. Altered proteolytic events in experimental autoimmune encephalomyelitis discovered by iTRAQ shotgun proteomics analysis of spinal cord Proteome Sci. 2009, 7, 25
20. Hu, J.; Qian, J.; Borisov, O.; Pan, S.; Li, Y.; Liu, T.; Deng, L.; Wannemacher, K.; Kurnellas, M.; Patterson, C.; Elkabes, S.; Li, H. Optimized proteomic analysis of a mouse model of cerebellar dysfunction using amine-specific isobaric tags Proteomics 2006, 6 (15) 4321-34
21. Liu, T.; DMello, V.; Deng, L.; Hu, J.; Ricardo, M.; Pan, S.; Lu, X.; Wadsworth, S.; Siekierka, J.; Birge, R.; Li, H. A multiplexed proteomics approach to differentiate neurite outgrowth patterns J. Neurosci. Methods 2006, 158 (1) 22-9
22. Tyler, W. A.; Jain, M. R.; Cifelli, S. E.; Li, Q.; Ku, L.; Feng, Y.; Li, H.; Wood, T. L. Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation Glia 2011, 59 (11) 1754-69
23. Reissner, K. J.; Uys, J. D.; Schwacke, J. H.; Comte-Walters, S.; Rutherford-Bethard, J. L.; Dunn, T. E.; Blumer, J. B.; Schey, K. L.; Kalivas, P. W. AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis J. Neurosci. 2011, 31 (15) 5648-58
24. Jain, M. R.; Liu, T.; Hu, J.; Darfler, M.; Fitzhugh, V.; Rinaggio, J.; Li, H. Quantitative proteomic analysis of formalin fixed paraffin embedded oral HPV lesions from HIV patients Open Proteomics J. 2008, 1, 40-5
25. Ostasiewicz, P.; Zielinska, D. F.; Mann, M.; Wisniewski, J. R. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry J. Proteome Res. 2010, 9 (7) 3688-700
26. Kawamura, T.; Nomura, M.; Tojo, H.; Fujii, K.; Hamasaki, H.; Mikami, S.; Bando, Y.; Kato, H.; Nishimura, T. Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) Stage-related protein candidates upon non-metastatic lung adenocarcinoma J. Proteomics 2010, 73 (6) 1089-99
27. Hood, B. L.; Darfler, M. M.; Guiel, T. G.; Furusato, B.; Lucas, D. A.; Ringeisen, B. R.; Sesterhenn, I. A.; Conrads, T. P.; Veenstra, T. D.; Krizman, D. B. Proteomic analysis of formalin-fixed prostate cancer tissue Mol. Cell. Proteomics 2005, 4 (11) 1741-53
28. Guzel, C.; Ursem, N. T.; Dekker, L. J.; Derkx, P.; Joore, J.; van Dijk, E.; Ligtvoet, G.; Steegers, E. A.; Luider, T. M. Multiple Reaction Monitoring assay for pre-eclampsia related calcyclin peptides in formalin fixed paraffin embedded placenta J. Proteome Res. 2011, 10 (7) 3274-82
29. Azimzadeh, O.; Barjaktarovic, Z.; Aubele, M.; Calzada-Wack, J.; Sarioglu, H.; Atkinson, M. J.; Tapio, S. Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics J. Proteome Res. 2010, 9 (9) 4710-20
30. Raine, C. S. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis Lab. Invest. 1984, 50 (6) 608-35
31. Martin, R.; McFarland, H. F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis Crit. Rev. Clin. Lab. Sci. 1995, 32 (2) 121-82
32. Hickey, W. F. The pathology of multiple sclerosis: a historical perspective J. Neuroimmunol. 1999, 98 (1) 37-44
33. Wekerle, H.; Kojima, K.; Lannes-Vieira, J.; Lassmann, H.; Linington, C. Animal models Ann. Neurol. 1994, 36 (Suppl) S47-53
34. Steinman, L. Assessment of animal models for MS and demyelinating disease in the design of rational therapy Neuron 1999, 24 (3) 511-4
35. van der Goes, A.; Dijkstra, C. D. Models for demyelination Prog. Brain Res. 2001, 132, 149-63
36. Swanborg, R. H. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease Clin. Immunol. Immunopathol. 1995, 77 (1) 4-13
37. Gold, R.; Hartung, H. P.; Toyka, K. V. Animal models for autoimmune demyelinating disorders of the nervous system Mol. Med. Today 2000, 6 (2) 88-91
38. Nicot, A.; Ratnakar, P. V.; Ron, Y.; Chen, C. C.; Elkabes, S. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction Brain 2003, 126 (Pt 2) 398-412
39. Nesvizhskii, A. I.; Aebersold, R. Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS Drug Discov. Today 2004, 9 (4) 173-81
40. Glickman, M. H.; Rubin, D. M.; Coux, O.; Wefes, I.; Pfeifer, G.; Cjeka, Z.; Baumeister, W.; Fried, V. A.; Finley, D. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3 Cell 1998, 94 (5) 615-23
41. Kisselev, A. F.; Goldberg, A. L. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates Methods Enzymol. 2005, 398, 364-78
42. Metz, B.; Kersten, G. F.; Hoogerhout, P.; Brugghe, H. F.; Timmermans, H. A.; de Jong, A.; Meiring, H.; ten Hove, J.; Hennink, W. E.; Crommelin, D. J.; Jiskoot, W. Identification of formaldehyde-induced modifications in proteins: reactions with model peptides J. Biol. Chem. 2004, 279 (8) 6235-43
43. Kerlero de Rosbo, N.; Milo, R.; Lees, M. B.; Burger, D.; Bernard, C. C.; Ben-Nun, A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein J. Clin. Invest. 1993, 92 (6) 2602-8
44. Zhang, Y.; Burger, D.; Saruhan, G.; Jeannet, M.; Steck, A. J. The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis Neurology 1993, 43 (2) 403-7
45. Sun, J.; Link, H.; Olsson, T.; Xiao, B. G.; Andersson, G.; Ekre, H. P.; Linington, C.; Diener, P. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis J. Immunol. 1991, 146 (5) 1490-5
46. Friese, M. A.; Fugger, L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005, 128 (Pt 8) 1747-63
47. Fugger, L.; Friese, M. A.; Bell, J. I. From genes to function: the next challenge to understanding multiple sclerosis Nat. Rev. Immunol. 2009, 9 (6) 408-17
48. Jilek, S.; Schluep, M.; Rossetti, A. O.; Guignard, L.; Le Goff, G.; Pantaleo, G.; Du Pasquier, R. A. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis Clin. Immunol. 2007, 123 (1) 105-13
49. Tsuchida, T.; Parker, K. C.; Turner, R. V.; McFarland, H. F.; Coligan, J. E.; Biddison, W. E. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides Proc. Natl. Acad. Sci. U.S.A. 1994, 91 (23) 10859-63
50. Dressel, A.; Chin, J. L.; Sette, A.; Gausling, R.; Hollsberg, P.; Hafler, D. A. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands J. Immunol. 1997, 159 (10) 4943-51
51. Sijts, A. J.; Ruppert, T.; Rehermann, B.; Schmidt, M.; Koszinowski, U.; Kloetzel, P. M. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes J. Exp. Med. 2000, 191 (3) 503-14
52. Gaczynska, M.; Rock, K. L.; Goldberg, A. L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes Nature 1993, 365 (6443) 264-7
53. Kloetzel, P. M.; Ossendorp, F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation Curr. Opin. Immunol. 2004, 16 (1) 76-81
54. Rivett, A. J.; Hearn, A. R. Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins Curr. Protein Pept. Sci. 2004, 5 (3) 153-61
55. Rock, K. L.; Goldberg, A. L. Degradation of cell proteins and the generation of MHC class I-presented peptides Annu. Rev. Immunol. 1999, 17, 739-79
56. Preckel, T.; Fung-Leung, W. P.; Cai, Z.; Vitiello, A.; Salter-Cid, L.; Winqvist, O.; Wolfe, T. G.; Von Herrath, M.; Angulo, A.; Ghazal, P.; Lee, J. D.; Fourie, A. M.; Wu, Y.; Pang, J.; Ngo, K.; Peterson, P. A.; Fruh, K.; Yang, Y. Impaired immunoproteasome assembly and immune responses in PA28-/- mice Science 1999, 286 (5447) 2162-5
57. Van den Eynde, B. J.; Morel, S. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome Curr Opin. Immunol. 2001, 13 (2) 147-53
58. Noda, C.; Tanahashi, N.; Shimbara, N.; Hendil, K. B.; Tanaka, K. Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats Biochem. Biophys. Res. Commun. 2000, 277 (2) 348-54
59. Ibrahim, S. M.; Mix, E.; Bottcher, T.; Koczan, D.; Gold, R.; Rolfs, A.; Thiesen, H. J. Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis Brain 2001, 124 (Pt 10) 1927-38
60. Fissolo, N.; Kraus, M.; Reich, M.; Ayturan, M.; Overkleeft, H.; Driessen, C.; Weissert, R. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation Eur. J. Immunol. 2008, 38 (9) 2401-11
61. Mishto, M.; Bellavista, E.; Ligorio, C.; Textoris-Taube, K.; Santoro, A.; Giordano, M.; DAlfonso, S.; Listi, F.; Nacmias, B.; Cellini, E.; Leone, M.; Grimaldi, L. M.; Fenoglio, C.; Esposito, F.; Martinelli-Boneschi, F.; Galimberti, D.; Scarpini, E.; Seifert, U.; Amato, M. P.; Caruso, C.; Foschini, M. P.; Kloetzel, P. M.; Franceschi, C. Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population PLoS One 2010, 5 (2) e9287
62. Zaiss, D. M.; Bekker, C. P.; Grone, A.; Lie, B. A.; Sijts, A. J. Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases J. Immunol. 2011, 187 (5) 2302-2309
63. Tang, S. C.; Lai, K. N. The ubiquitin-proteasome pathway and IgA nephropathy: a novel link? Kidney Int. 2009, 75 (5) 457-9
64. Mishto, M.; Ligorio, C.; Bellavista, E.; Martucci, M.; Santoro, A.; Giulioni, M.; Marucci, G.; Franceschi, C. Immunoproteasome expression is induced in mesial temporal lobe epilepsy Biochem. Biophys. Res. Commun. 2011, 408 (1) 65-70
65. Mishto, M.; Bellavista, E.; Santoro, A.; Stolzing, A.; Ligorio, C.; Nacmias, B.; Spazzafumo, L.; Chiappelli, M.; Licastro, F.; Sorbi, S.; Pession, A.; Ohm, T.; Grune, T.; Franceschi, C. Immunoproteasome and LMP2 polymorphism in aged and Alzheimers disease brains Neurobiol. Aging 2006, 27 (1) 54-66
66. Diaz-Hernandez, M.; Martin-Aparicio, E.; Avila, J.; Hernandez, F.; Lucas, J. J. Enhanced induction of the immunoproteasome by interferon gamma in neurons expressing mutant Huntingtin Neurotox. Res. 2004, 6 (6) 463-8
67. Diaz-Hernandez, M.; Hernandez, F.; Martin-Aparicio, E.; Gomez-Ramos, P.; Moran, M. A.; Castano, J. G.; Ferrer, I.; Avila, J.; Lucas, J. J. Neuronal induction of the immunoproteasome in Huntingtons disease J. Neurosci. 2003, 23 (37) 11653-61
68. Frausto, R. F.; Crocker, S. J.; Eam, B.; Whitmire, J. K.; Whitton, J. L. Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency J. Neuroimmunol. 2007, 192 (1-2) 124-33
69. Vanderlugt, C. L.; Rahbe, S. M.; Elliott, P. J.; Dal Canto, M. C.; Miller, S. D. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519 J. Autoimmun. 2000, 14 (3) 205-11
70. Hosseini, H.; Andre, P.; Lefevre, N.; Viala, L.; Walzer, T.; Peschanski, M.; Lotteau, V. Protection against experimental autoimmune encephalomyelitis by a proteasome modulator J. Neuroimmunol. 2001, 118 (2) 233-44
71. Scheffler, S.; Kuckelkorn, U.; Egerer, K.; Dorner, T.; Reiter, K.; Soza, A.; Burmester, G. R.; Feist, E. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i) Rheumatology (Oxford) 2008, 47 (5) 622-6
72. Egerer, T.; Martinez-Gamboa, L.; Dankof, A.; Stuhlmuller, B.; Dorner, T.; Krenn, V.; Egerer, K.; Rudolph, P. E.; Burmester, G. R.; Feist, E. Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjogrens syndrome Arthritis Rheum. 2006, 54 (5) 1501-8
73. Krause, S.; Kuckelkorn, U.; Dorner, T.; Burmester, G. R.; Feist, E.; Kloetzel, P. M. Immunoproteasome subunit LMP2 expression is deregulated in Sjogrens syndrome but not in other autoimmune disorders Ann. Rheum. Dis. 2006, 65 (8) 1021-7
74. Muchamuel, T.; Basler, M.; Aujay, M. A.; Suzuki, E.; Kalim, K. W.; Lauer, C.; Sylvain, C.; Ring, E. R.; Shields, J.; Jiang, J.; Shwonek, P.; Parlati, F.; Demo, S. D.; Bennett, M. K.; Kirk, C. J.; Groettrup, M. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis Nat. Med. 2009, 15 (7) 781-7
75. Basler, M.; Dajee, M.; Moll, C.; Groettrup, M.; Kirk, C. J. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome J. Immunol. 2010, 185 (1) 634-41